(Q85554027)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23187732%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

title

Ubiquitin- and ubiquitin-like proteins-conjugating enzymes (E2s) in breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23187732%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author

Ioannis A. Voutsadakis

series ordinal

1

object named as

Ioannis A Voutsadakis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23187732%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

28 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23187732%20AND%20SRC:MED&resulttype=core&format=json

Molecular Biology Reports

18 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23187732%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23187732%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23187732%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

2019-2034

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23187732%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11033-012-2261-0

18 February 2020

exact match

0 references

cites work

Expression of the novel human gene, UBE2Q1, in breast tumors.

1 reference

12 December 2020

Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2.

1 reference

12 December 2020

The ubiquitin-proteasome system as a molecular target in solid tumors: an update on bortezomib.

1 reference

12 December 2020

Systematic in vivo RNAi analysis identifies IAPs as NEDD8-E3 ligases

1 reference

12 December 2020

Evolutionary pathways in BRCA1-associated breast tumors

1 reference

12 December 2020

Long-range transcriptional control of progesterone receptor gene expression

1 reference

12 December 2020

NEDD8 recruits E2-ubiquitin to SCF E3 ligase.

1 reference

12 December 2020

Proteasome inhibition represses ERalpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer

1 reference

12 December 2020

Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer

1 reference

12 December 2020

Sensitization against anticancer drugs by transfection with UBE2I variant gene into ras-NIH3H3 mouse fibroblasts.

1 reference

12 December 2020

Small-molecule inhibitors of MDM2 as new anticancer therapeutics

1 reference

12 December 2020

Basis for a ubiquitin-like protein thioester switch toggling E1–E2 affinity

1 reference

12 December 2020

Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitors

1 reference

12 December 2020

Estrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cells

1 reference

12 December 2020

Key signalling nodes in mammary gland development and cancer. Signalling downstream of PI3 kinase in mammary epithelium: a play in 3 Akts

1 reference

12 December 2020

NUB1 promotes cytoplasmic localization of p53 through cooperation of the NEDD8 and ubiquitin pathways

1 reference

12 December 2020

Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer

1 reference

12 December 2020

Mechanism of BRCA1-mediated inhibition of progesterone receptor transcriptional activity

1 reference

12 December 2020

Analysis of a novel human gene, LOC92912, over-expressed in hypopharyngeal tumours.

1 reference

12 December 2020

The family of ubiquitin-conjugating enzymes (E2s): deciding between life and death of proteins

1 reference

12 December 2020

BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer

1 reference

12 December 2020

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

1 reference

12 December 2020

The ubiquitin-proteasomal system is critical for multiple myeloma: implications in drug discovery

1 reference

12 December 2020

Revealing targeted therapy for human cancer by gene module maps.

1 reference

12 December 2020

Harnessing synthetic lethal interactions in anticancer drug discovery

1 reference

12 December 2020

The docking protein p130Cas regulates cell sensitivity to proteasome inhibition

1 reference

12 December 2020

Targeting protein neddylation: a novel therapeutic strategy for the treatment of cancer

1 reference

12 December 2020

E2s: structurally economical and functionally replete

1 reference

12 December 2020

RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis

1 reference

12 December 2020

Personalized treatment of early-stage breast cancer: present concepts and future directions

1 reference

12 December 2020

An allosteric inhibitor of the human Cdc34 ubiquitin-conjugating enzyme

1 reference

12 December 2020

Proteasome inhibitors: an expanding army attacking a unique target

1 reference

12 December 2020

The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-alpha and essential for the antiproliferative activity of ICI 182,780 in ERalpha-positive breast cancer cells

1 reference

12 December 2020

Overexpression of the novel human gene, UBE2Q2, in breast cancer.

1 reference

12 December 2020

Crystal structure of the cyclin-specific ubiquitin-conjugating enzyme from clam, E2-C, at 2.0 A resolution

1 reference

12 December 2020

Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.

1 reference

12 December 2020